Socioeconomic Costs of Chronic Kidney Disease: Evidence from Southwest Vietnam
Introduction: Chronic Kidney Disease (CKD) has a high mortality in developing countries. This burden is increasing rapidly in Vietnam. The high cost of medication and haemodialysis are major barriers in the successful treatment of CKD. Aim: To determine from a societal perspective the complete cost...
Saved in:
| Published in: | Journal of clinical and diagnostic research Vol. 12; no. 6; pp. LC99 - LC105 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
01-06-2018
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: Chronic Kidney Disease (CKD) has a high mortality in developing countries. This burden is increasing rapidly in Vietnam. The high cost of medication and haemodialysis are major barriers in the successful treatment of CKD. Aim: To determine from a societal perspective the complete cost associated with CKD. Materials and Methods: A cross-sectional study was conducted to estimate the total costs associated with the cost-of-illness, based on the prevalence of the disease at Kien Giang General Hospital. An electronic database provided information related to direct medical costs and biochemical parameters, whereas face-to-face interviews with CKD patients were conducted by questionnaire to collect demographic characteristics, direct nonmedical costs and indirect costs. The population was divided into three groups based on the stages of CKD including the CKD 1–3 group, CKD 4–5 pre-dialysis group and haemodialysis group. Results: A total of 327 patients were enrolled in the study. Costs varied among three groups of CKD patients. The annual cost per patient in the CKD 1–3 group, CKD 4-5 pre-dialysis group and haemodialysis group were USD 2,826.3 (95%CI: 2,592.3– 3,077.1), USD 3,320.3 (95%CI: 2,765.2–3,913.8) and USD 9,498.3 (95%CI: 9,152.5–9,881.4), respectively. Direct medical costs represented the greatest proportion of total costs. The annual cost per patient in the CKD 1–3 group was affected by many characteristics such as age, residence, BMI, education level, exercise and number of comorbidities. In contrast to the CKD 1–3 group, in the haemodialysis group most results were not significantly different in the yearly cost per patient according to demographic and clinical characteristics. Whereas, patients in the CKD 4–5 pre-dialysis group were impacted by factors such as age, residence, occupation and the number of comorbidities. Conclusion: The annual cost per patient in CKD 1–3, CKD 4–5 pre-dialysis and haemodialysis groups were substantial. Patients on haemodialysis incurred the highest cost, about three times compared with the other two groups. The differences in demographic and clinical characteristics affected the annual cost per patient, especially in the CKD 1–3 group. |
|---|---|
| ISSN: | 2249-782X 0973-709X |
| DOI: | 10.7860/JCDR/2018/36719.11716 |